Literature DB >> 17484127

Functions of the histone chaperone nucleolin in diseases.

Sébastien Storck1, Manu Shukla, Stefan Dimitrov, Philippe Bouvet.   

Abstract

Alteration of nuclear morphology is often used by pathologist as diagnostic marker for malignancies like cancer. In particular, the staining of cells by the silver staining methods (AgNOR) has been proved to be an important tool for predicting the clinical outcome of some cancer diseases. Two major argyrophilic proteins responsible for the strong staining of cells in interphase are the nucleophosmin (B23) and the nucleolin (C23) nucleolar proteins. Interestingly these two proteins have been described as chromatin associated proteins with histone chaperone activities and also as proteins able to regulate chromatin transcription. Nucleolin seems to be over-expressed in highly proliferative cells and is involved in many aspect of gene expression: chromatin remodeling, DNA recombination and replication, RNA transcription by RNA polymerase I and II, rRNA processing, mRNA stabilisation, cytokinesis and apoptosis. Interestingly, nucleolin is also found on the cell surface in a wide range of cancer cells, a property which is being used as a marker for the diagnosis of cancer and for the development of anti-cancer drugs to inhibit proliferation of cancer cells. In addition to its implication in cancer, nucleolin has been described not only as a marker or as a protein being involved in many diseases like viral infections, autoimmune diseases, Alzheimer's disease pathology but also in drug resistance. In this review we will focus on the chromatin associated functions of nucleolin and discuss the functions of nucleolin or its use as diagnostic marker and as a target for therapy

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484127     DOI: 10.1007/1-4020-5466-1_7

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  50 in total

1.  Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinase.

Authors:  Claudia Perrera; Riccardo Colombo; Barbara Valsasina; Patrizia Carpinelli; Sonia Troiani; Michele Modugno; Laura Gianellini; Paolo Cappella; Antonella Isacchi; Jurgen Moll; Luisa Rusconi
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

Review 2.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

Review 3.  Genetic control of quiescence in hematopoietic stem cells.

Authors:  Takeshi Yamada; Chun Shik Park; H Daniel Lacorazza
Journal:  Cell Cycle       Date:  2013-06-28       Impact factor: 4.534

4.  A new twist on plasma membrane repair.

Authors:  Ronald L Mellgren
Journal:  Commun Integr Biol       Date:  2011-03

5.  A novel post-translational modification of nucleolin, SUMOylation at Lys-294, mediates arsenite-induced cell death by regulating gadd45α mRNA stability.

Authors:  Dongyun Zhang; Yuguang Liang; Qipeng Xie; Guangxun Gao; Jinlong Wei; Haishan Huang; Jingxia Li; Jimin Gao; Chuanshu Huang
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

6.  The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomas.

Authors:  Jiafeng Qi; Huiling Li; Nanbo Liu; Yutong Xing; Gang Zhou; Yao Wu; Yuanhang Liu; Wenxia Chen; Jie Yue; Bater Han; Shirong Kang; Xu Wu
Journal:  Med Oncol       Date:  2015-01-29       Impact factor: 3.064

7.  Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.

Authors:  Diala El Khoury; Damien Destouches; Renée Lengagne; Bernard Krust; Yamina Hamma-Kourbali; Marylène Garcette; Sandra Niro; Masashi Kato; Jean-Paul Briand; José Courty; Ara G Hovanessian; Armelle Prévost-Blondel
Journal:  BMC Cancer       Date:  2010-06-24       Impact factor: 4.430

8.  NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling.

Authors:  Mikael S Lindström
Journal:  Biochem Res Int       Date:  2010-10-05

9.  Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.

Authors:  John S Vorhies; John J Nemunaitis
Journal:  Biologics       Date:  2007-12

10.  Interplay between REST and nucleolin transcription factors: a key mechanism in the overexpression of genes upon increased phosphorylation.

Authors:  Teeo Tediose; Martin Kolev; Baalasubramanian Sivasankar; Paul Brennan; B Paul Morgan; Rossen Donev
Journal:  Nucleic Acids Res       Date:  2010-01-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.